The Artificial Intelligence in Drug Discovery Market is expanding rapidly as machine learning algorithms accelerate hit identification, lead optimization, and toxicity prediction. Growing demand for reduced drug development timelines and costs, along with increasing partnerships between pharma and AI companies, is significantly strengthening market growth.According to Market Research Future analysis, the Artificial Intelligence (AI) in Drug Discovery Market was estimated at 0.93 USD Billion in 2024. The AI in Drug Discovery industry is projected to grow from 1.172 USD Billion in 2025 to 11.82 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 26% during the forecast period 2025 - 2035. North America led the market with over 45% share, generating around USD 0.4 billion in revenue.
Read More Detailed Insights:
www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393
Key growth drivers include increasing availability of large-scale biological datasets, rising adoption of generative AI for novel molecule design, and growing validation of AI-discovered drugs entering clinical trials. Advances in deep learning for protein structure prediction and de novo design are further propelling market expansion.
Regionally, North America leads with concentrated AI biotech startups and pharma partnerships. Europe follows with growing AI research hubs, while the Asia-Pacific region is emerging rapidly as AI talent and investment expand across China.
Related Reports:
Biomaterials Market
Biosimulation Market
Dental Consumables Market
Clinical Laboratory Services Market
Arteriovenous Malformation Market
US HIV Diagnostics Market
China Companion Diagnostics Oncology Market
Foot Ankle Device Market
HER2 Negative Breast Cancer Market
AI in Radiology Market